30-month stay targeted in latest US pharma patent reform legislation
The REMEDY Act is part of a growing legislative narrative seeking to curtail high medicine prices by targeting the nexus of litigation and regulatory drug approval
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.